These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34165683)

  • 1. Can PET/CT be used more effectively in pleural effusion evaluation?
    Simsek FS; Yuksel D; Yaylali O; Aslan HS; Kılıçarslan E; Bir F; Arslan M; Can FE; Ugurlu E
    Jpn J Radiol; 2021 Dec; 39(12):1186-1194. PubMed ID: 34165683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of PET/CT to the differentiation of benign and malignant pleural effusion in patients with ovarian carcinoma.
    Budak A; Yanarateş A; Budak E
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):353-358. PubMed ID: 37172933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How can we use positron emission tomography/computed tomography more accurately for characterization of asbestos-related pleural thickening?
    Simsek FS; Cakmak M; Kuslu D; Balci TA; In E; Ozercan IH; Narin Y
    Arch Med Sci; 2023; 19(2):385-391. PubMed ID: 37034512
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Taralli S; Scolozzi V; Foti M; Ricciardi S; Forcione AR; Cardillo G; Calcagni ML
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):429-436. PubMed ID: 30535767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
    Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
    Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
    Yang MF; Tong ZH; Wang Z; Zhang YY; Xu LL; Wang XJ; Li W; Wu XZ; Wang W; Zhang YH; Jiang T; Shi HZ
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1457-1467. PubMed ID: 30903197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating malignant and benign pleural effusion in patients with lung cancer: an
    Zhang W; Liu Z; Duan X; Li Y; Shen C; Guo Y; Yang J
    Front Oncol; 2023; 13():1192870. PubMed ID: 37456249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation and validation of a 18F-FDG PET/CT scoring model to predict malignant pleural effusion.
    Lu P; Sun Y; Liang B; Yu L
    Nucl Med Commun; 2022 Feb; 43(2):177-185. PubMed ID: 34864810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on
    Li Y; Mu W; Li Y; Song X; Huang Y; Jiang L
    EJNMMI Res; 2021 Oct; 11(1):108. PubMed ID: 34652524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET of pleural effusions in patients with non-small cell lung cancer.
    Erasmus JJ; McAdams HP; Rossi SE; Goodman PC; Coleman RE; Patz EF
    AJR Am J Roentgenol; 2000 Jul; 175(1):245-9. PubMed ID: 10882281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.
    Gupta NC; Rogers JS; Graeber GM; Gregory JL; Waheed U; Mullet D; Atkins M
    Chest; 2002 Dec; 122(6):1918-24. PubMed ID: 12475827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
    AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.
    Sun Y; Yu H; Ma J; Lu P
    PLoS One; 2016; 11(8):e0161764. PubMed ID: 27560933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph nodes rather than pleural metabolic activity in
    Jiang Y; Liu T; Xu K; Cheng Q; Lu W; Xie J; Chen M; Li Y; Du Y; Liang S; Song Y; Wu J; Lv T; Zhan P
    Transl Lung Cancer Res; 2024 Sep; 13(9):2236-2253. PubMed ID: 39430341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving diagnostic performance of
    Yang DD; Mirvis E; Goldring J; Patel ARC; Wagner T
    Clin Radiol; 2019 Oct; 74(10):818.e17-818.e23. PubMed ID: 31420186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    AJR Am J Roentgenol; 2018 Dec; 211(6):1354-1360. PubMed ID: 30300005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
    Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.